Modelling the cost-effectiveness of PCSK9 inhibitors vs. ezetimibe through LDL-C reductions in a Norwegian setting
Peer reviewed, Journal article
View/ Open
Date
2017Metadata
Show full item recordCollections
- Artikler [5275]
- Publikasjoner fra CRIStin FHI [7785]